Over the past decade or so, the means of producing diagnostic images have improved greatly, but the technology for reading them has failed to keep pace. Radiologists read new computerized images with hand-held magnifying glasses, calipers and rulers, the same tools used for years. R2 Technology, by providing radiologists with better means of reading images through computer-aided detection software, is looking to carve out a niche in the diagnostic imaging market, where few small companies have ventured successfully. R2 is the first-to-market with FDA-approved CAD technology for breast cancer screening, and plans to develop this as a platform technology for other cancers, betting that its first-mover advantage helps establish the industry standard.
by Stephen Levin
Dan Kopans, MD, a prominent radiologist at the Massachusetts General Hospital , starts his mammography seminars by asking how...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights